US SEC Trading Suspension Halt Orders — May 13, 2026

Failed to hold annual shareholders' meeting within 12 months of FYE April 30, 2026, violating Nasdaq Rule 5620(a)

45-day window to submit compliance plan by June 22, 2026, with no assurance of Nasdaq acceptance despite intended proxy timeline

Potential extension only up to 180 days (October 27, 2026) if plan approved, signaling prolonged uncertainty

Closing bid price below $1.00 for 30 consecutive trading days March 25-May 6, 2026, vs prior compliance, violating Rule 5550(a)(2)

180-day grace period to November 3, 2026 requires $1.00 close for 10 consecutive business days, highlighting recent QoQ price deterioration

Second 180-day extension eligibility tied to other standards and reverse split plan notification, implying dilution risk

Nasdaq Hearings Panel delisting notice May 12, 2026 after missing final May 11 compliance deadline under Rule 5550(a)(2)

Trading suspension effective market open May 14, 2026, with shift to OTCQB, no period recovery in bid price

Post-delisting risks include reduced liquidity, impaired financing, penny stock status vs prior Nasdaq trading

Negative sentiment uniform across 3 filings (materiality 9-10/10), no offsetting insider buys or positive forward guidance

2/3 filings show bid price non-compliance over 30-day recent periods, outlier governance fail in CEA

No immediate listing impact but ongoing non-compliance vs historical standards signals management execution concerns

No annual meeting held within 12 months post-FYE April 30, 2026, eroding shareholder oversight

Compliance plan due June 22, 2026; rejection leads to suspension, extension max October 27

30 consecutive days below $1 March 25-May 6, 2026, with no QoQ recovery trend

Uncertain eligibility for additional 180 days beyond November 3, 2026 without meeting other standards

Nasdaq trading halts May 14, 2026 open, immediate liquidity hit post-May 11 deadline miss

Move to OTCQB Venture Market under RVPH risks 50%+ liquidity drop, penny stock rules

Delisting impairs capital access, analyst coverage loss vs prior Nasdaq status

Potential classification post-delisting increases volatility, regulatory scrutiny

Reverse stock split likely needed for compliance extension, eroding shareholder value

Stated intent to hold meeting soon but no firm timeline or assurance

Successful June 22, 2026 submission and acceptance could avert delisting, extension to Oct 27 offers recovery window

Proxy timeline in plan may restore governance, potential catalyst if held pre-October

180 days to Nov 3, 2026 to hit $1 for 10 consec days, relative outperformance vs delisted Reviva

Notify Nasdaq of reverse split or strategy for 2nd 180 days, appeal rights add upside optionality

Continued Nasdaq trading during grace period vs Reviva's suspension creates relative stability

Speculative trading on OTCQB post-May 14, 2026 under RVPH for illiquid value hunters

Confirmed delisting May 14 likely spikes volatility, short ahead of suspension

Sidestep Nasdaq small caps with bid <1 or governance flags, alpha via underweight vs index

Intrusion's 180-day grace outperforms Reviva's immediate halt, long/short pair trade

180-day max if approved beats Reviva's zero grace, monitor for outperformance

2/3 companies (Intrusion, Reviva) with < $1 closes over 30-day periods March-May 2026, signaling small-cap price weakness vs historical compliance

CEA (45+180 days), Intrusion (180+180 days) vs Reviva (expired), avg 135-day window offers relative breathing room

CEAs 12-month meeting delay post-FYE highlights control lapses absent in peers, no capital allocation positives

Reviva's May 14 shift to OTCQB exemplifies trend, risks uniform liquidity compression across filings

Key dates June 22 (CEA plan), Nov 3 (Intrusion), post-May 14 (Reviva) create near-term catalyst density in Nasdaq Capital Market

Zero reported insider buys/sells/pledges across 3 filings, contrasting potential concern in distress situations

Submit by June 22, 2026; Nasdaq acceptance determines delisting path [June 22, 2026]

Up to 180 days from Nasdaq if plan approved, monitor meeting timeline [October 27, 2026]

Track for 10 consecutive $1+ closes during 180-day grace [November 3, 2026]

Plan submission for 2nd 180 days if initial compliance fails [Ongoing post-Nov 3]

Right to appeal delisting to Nasdaq Panel if grace expires [TBD post-Nov 3]

Nasdaq halt at open, confirm OTCQB transition [May 14, 2026]

Monitor liquidity/price on RVPH post-delisting [Ongoing from May 14]

Scan Nasdaq Capital Market for similar bid/governance notices in small caps [Weekly]